Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire

Table 1 Number of cancer survivors per cancer site and per region included in phase 1a and 1b

	Phase 1a	Phase 1b
Cancer site
Bladder	7	32
Breast	17	53
Colorectal	12	46
Glioma	10	36
Gynecological	12	49
Head & neck	10	44
Lung	8	41
Lymphoma	9	38
Melanoma	11	38
Prostate	11	44
Testicular	10	37
Total	117	458
Region
Northern Europe	30	147
Southern Europe	46	126
English speaking	13	98
Central Europe	28	87
Time since diagnosis
0.5 to 2 years	21	111
2 to 5 years	63	189
more than 5 years	33	158
Time since completing last treatment^a
0.5 to 1 year	–	72
1 to 2 years	–	105
2 to 5 years	–	172
more than 5 years	–	109

For phase 1b only, also the number of survivors per time since completion of last treatment category is reported
^aFor phase 1a only information was available regarding date of diagnosis and date of recurrence

ISSN: 1477-7525